Cardiac Resynchronization Therapy Market
Cardiac Resynchronization Therapy Market Analysis by Product Type (CRT-Defibrillator, RT-Pacemaker), by End-user Type, by Region - Global Forecast 2022-2032
Analysis of Cardiac Resynchronization Therapy market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Cardiac Resynchronization Therapy Market Outlook
Newly-released Cardiac Resynchronization Therapy industry analysis report by Fact.MR shows that global sales of Cardiac Resynchronization Therapy in 2021 were held at US$ 5.7 Bn. With 7.9%, the projected market growth during 2022-2032 is expected to be slightly lower than the historical growth. CRT-Defibrillator is expected to be the higher revenue-generating product, accounting for an absolute dollar opportunity of nearly US$ 4 Bn during 2022 – 2032.
Revenue of Cardiac Resynchronization Therapy from 2017 to 2021 Compared to Demand Outlook for 2022 to 2032
As per the Cardiac Resynchronization Therapy industry research by Fact.MR - market research and competitive intelligence provider, historically, from 2017 to 2021, the market value of the Cardiac Resynchronization Therapy industry increased at around 8.0% CAGR, wherein, countries such as the U.S., China, Canada, India, and the UK held a significant share in the global market.
The increasing prevalence of diseases is driving the market's growth (primarily due to the rising geriatric population). Rising investments and support, as well as technology improvements, are all helping to drive this market forward.
- The Cardiac Resynchronization Therapy market reached a valuation of US$ 5.7 Bn in 2021 and it grew by 9.2% as compared to the previous year’s value which stood at US$ 5.2 Bn. Fact.MR estimates that cardiac resynchronization therapy revenue will grow from 2022 to 2032, reaching nearly US$ 13.2 Bn in 2032.
- The CRT-Defibrillator and CRT-Pacemaker product types segments of The Cardiac Resynchronization Therapy market reflected the market size of US$ 3.4Bn and US$ 2.3 Bn respectively in the year 2021
- From the end-user perspective, hospitals seized more than 50% market share in the year 2021.
- From the North America region, the United States is the leading country with a valuation of US$ 2.08 Bn in the year 2021
What are the Key Factors on the Basis of which Cardiac Resynchronization Therapy Market has been growing?
Device for cardiac resynchronization therapy that is CRT-D defibrillators combine the functions of an implanted cardioverter-defibrillator and a defibrillator to quickly resynchronize a dangerously fast cardiac rhythm. Cardiac resynchronization treatment is for patients with severe and moderate cardiac failure, pacemakers and defibrillators are becoming more significant therapeutic tools.
The devices for cardiac resynchronization therapy are implanted in the body. The pacemaker is small enough to fit in the palm of your hand and is inserted just below the collarbone. The device's leads monitor the heart rate to detect heart rate anomalies and send out tiny pulses to resynchronize the ventricles of the heart. The therapeutic gadget helps to improve heart rhythm and the symptoms of arrhythmia. Owing to these factors cardiac resynchronization therapy market is projected to grow in leaps and bounds.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
What Factors are pushing the Cardiac Resynchronization Therapy Market Ahead?
The growing cases of cardiovascular disease (CVD), the increasing number of surgical procedures performed, and the expanding number of critical care and intensive care units are some of the key factors driving the growth of the Cardiac Resynchronization Therapy market.
The global cardiac resynchronization therapy device market is being driven by awareness campaigns done by various healthcare sectors as well as government organizations for spreading knowledge related to the heart and ailments associated with it.
Cardiac resynchronization therapy is improving the clinical symptoms of patients with heart failure who have a ventricular conduction delay over time, making it a go-to option in today’s date with a positive trend.
What Factors are restraining the Cardiac Resynchronization Therapy Market?
The high cost of the cardiac resynchronization therapy device, as well as a lack of educated and skilled experts are limiting the growth of the cardiac resynchronization therapy market. Furthermore, the lack of data format interoperability is limiting the growth of cardiac resynchronization therapy.
Which Region is projected to offer the Largest Opportunity for Cardiac Resynchronization Therapy?
The market for cardiac resynchronization therapy in North America is growing at a steady pace. In 2021, North America had the highest revenue share of more than 40%. The growing geriatric population and regulatory clearances are responsible for the region's substantial proportion. Research and innovation are being aided by increased access to large historical data in the sector. The American College of Cardiology (ACC) announced a suite of cardiovascular data registries in April 2021, allowing healthcare companies to assess and improve service quality using existing data.
The rising frequency of cardiovascular illnesses, the increased risk of obesity, rising disposable incomes, and the presence of multiple market competitors are some of the primary drivers of the regional market.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
How Cardiac Resynchronization Therapy is improving heart failure management?
Although CRT is frequently considered only after the implementation of optimal medical heart failure therapy, it should be noted that only a small percentage of patients can tolerate maximal doses of neurohormonal blockers before CRT implantation. On the other hand, the acute and chronic haemodynamic effects of CRT may significantly alter the tolerability and acceptance of medical therapy.
CRT protects patients from AV conduction slowdown, bradycardia, and sinoatrial nodal pauses, allowing for safe beta-blocker titration. Furthermore, observational and randomized evidence implies that cardiac rehabilitation after CRT implant is linked to greater functional improvement and lower heart failure hospitalization and mortality.
How is Elderly Population Expected to Contribute Significantly to the Cardiac Resynchronization Therapy Market?
The Heart Rhythm Society produced guidelines for managing patients with cardiac implantable electronic devices in April 2020 COVID-19 task force update. This was done to put an emphasis on limiting exposure to patients and physicians. The elderly population is expected to be a key driver for market expansion. Statistics Korea estimates that 8.5 Mn people aged 65 and up will be alive in 2021.
By 2030, this figure is predicted to rise to 12.9 Mn. Chronic disorders such as congestive heart failure, hypertension, and arrhythmia are becoming more common as the population ages. This is expected to add to the market growth of the country. In a study published in the Archives of Cardiovascular Diseases in 2019, the European Society of Cardiology discovered that French patients are more likely than the rest of Europe to obtain a CRT-P implant.
What Techniques are Being Used to Combat the Underuse of Cardiac Resynchronization Therapy?
Improved ways to identify prospective eligible CRT candidates by cardiologists and non-cardiologists are urgently needed, as a referral is one of the barriers to installation. In addition, ECG surveillance in heart failure patients is recommended since anomalies not only provide information on the underlying cause but also aid in the selection of appropriate therapy.
Involvement with patient organizations or support groups on a more personal level could help to increase the spread of information about therapy choices. More actionable referrals could be triggered by screening through automated alerts in electronic health records based on information from QRS duration, left ventricular (LV) function, and heart failure state. Screening for individuals eligible for optimization of heart failure therapy, including CRT, may be as effective as it has been for other heart failure treatments, with the proliferation of electronic health data.
Country-wise Analysis
Which Country represents the Strongest Revenue Potential in the Coming years for Cardiac Resynchronization Therapy Revenue?
According to the American Heart Association's Heart & Stroke Statistics report from 2020, about 356,000 cases of out-of-hospital cardiac arrest (OHCA) occur in the United States each year, with around 90% of these being fatal. In such cases, Cardiac resynchronization therapy (CRT) becomes a mode of solution.
Category-wise Insights
Why CRT-Defibrillator is Gaining the Utmost Traction when compared with CRT-Pacemaker?
In 2021, the CRT-defibrillators product segment was more profitable, accounting for more than 58% of global revenue. This is mostly due to the growing recognition of CRT-Ds as a viable alternative to pacemakers, as well as the introduction of technologically improved devices.
According to a study by National Cardiovascular Data Registry for implantable cardioverter-defibrillators, conducted on over 85,000 new CRT-D implants patients, there has been an increase in guideline-concordant implantation during the time in a study of through the.
How has COVID-19 Eventually Harmed the Revenue Generation from Cardiac Resynchronization Therapy?
The COVID-19 pandemic affected the market, resulting in lower demand and sales. This was due to cancelled elective treatments as a result of the pandemic, as well as delays in clinical trials, supply chain issues, and reduced sales and marketing activity.
MicroPort, one of the leading market players saw a 16.2% drop in its cardiac rhythm management business. The business blamed the drop on the COVID-19 epidemic, which caused outpatient appointments and surgical procedures to be postponed, resulting in fewer implants.
Competitive Analysis
During the projection period, market competition is expected to be moderate. Medtronic, Abbott, Boston Scientific Corporation, MicroPort BIOTRONIK, and Medico are all major competitors in the cardiac resynchronization therapy industry.
These businesses have a wealth of resources, market knowledge, a strong distribution network, and are engaged in strategic initiatives to expand market share and profitability. Mergers and acquisitions, regional expansion, collaborations, the launch of new goods, and R&D operations are all instances of these tactics.
Some of the recent developments of Cardiac Resynchronization Therapy providers are as follows :
- In January 2022, Medtronic has announced a $4 million initiative to increase diversity in STEM professions.
- In February 2020, Abbott introduced the latest gallant implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices that have achieved CE Mark, offering the most modern heart rhythm management capabilities to patients.
- In March 2019, BIOTRONIK introduced the world's smallest 3T full-body MR conditional ICD and CRT-D devices in the European market.
Similarly, recent developments related to companies offering Cardiac Resynchronization Therapy have been tracked by the team at Fact.MR, which are available in the full report.
Cardiac Resynchronization Therapy Report Scope
|
Report Attribute |
Details |
|
Forecast Period |
2022-2032 |
|
Historical Data Available for |
2017-2021 |
|
Key Countries Covered |
|
|
Key Companies Profiled |
|
Market Segments Covered in Cardiac Resynchronization Therapy Industry Analysis
-
By Product Type :
- CRT-Defibrillator
- CRT-Pacemaker
-
By End-user Type :
- Hospital
- Cardiac Center
- Other End-users
-
By region :
- North America
- Latin America
- Europe
- APAC
- MEA
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Summary of Statistics 1.3. Key Market Characteristics & Attributes 1.4. Fact.MR Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Risks and Trends Assessment 3.1. Risk Assessment 3.1.1. COVID-19 Crisis and Impact on Cardiac Resynchronization Therapy Demand 3.1.2. COVID-19 Impact Benchmark with Previous Crisis 3.1.3. Impact on Market Value (US$ Mn) 3.1.4. Assessment by Key Countries 3.1.5. Assessment by Key Market Segments 3.1.6. Action Points and Recommendation for Suppliers 3.2. Key Trends Impacting the Market 3.3. Formulation and Product Development Trends 4. Market Background and Foundation Data Points 4.1. Cardiac Resynchronization Therapy Market (US$ Mn) 4.2. Cardiac Resynchronization Therapy Market Opportunity Assessment (US$ Mn) 4.2.1. Total Available Market 4.2.2. Serviceable Addressable Market 4.2.3. Serviceable Obtainable Market 4.3. Market Scenario Forecast 4.3.1. Demand in optimistic Scenario 4.3.2. Demand in Likely Scenario 4.3.3. Demand in Conservative Scenario 4.4. Investment Feasibility Analysis 4.4.1. Investment in Established Markets 4.4.1.1. In Short Term 4.4.1.2. In Long Term 4.4.2. Investment in Emerging Markets 4.4.2.1. In Short Term 4.4.2.2. In Long Term 4.5. Forecast Factors - Relevance & Impact 4.5.1. Top Companies Historical Growth 4.5.2. Cardiac Resynchronization Therapy Market Growth 4.5.3. Cardiac Resynchronization Therapy Adoption Rate, By Country 4.6. Market Dynamics 4.6.1. Market Driving Factors and Impact Assessment 4.6.2. Prominent Market Challenges and Impact Assessment 4.6.3. Cardiac Resynchronization Therapy Market Opportunities 4.6.4. Prominent Trends in the Global Market & Their Impact Assessment 5. Key Success Factors 5.1. Manufacturers’ Focus on Low Penetration High Growth Markets 5.2. Banking on with Segments High Incremental Opportunity 5.3. Peer Benchmarking 6. Cardiac Resynchronization Therapy Market Demand Analysis 2017-2021 and Forecast, 2022-2032 6.1. Historical Market Analysis, 2017-2021 6.2. Current and Future Market Projections, 2022-2032 6.3. Y-o-Y Growth Trend Analysis 7. Cardiac Resynchronization Therapy Market Value Analysis 2017-2021 and Forecast, 2022-2032 7.1. Historical Market Value (US$ Mn) Analysis, 2017-2021 7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Cardiac Resynchronization Therapy Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2017-2021 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2022-2032 8.3.1. CRT-Defibrillator 8.3.2. CRT-Pacemaker 8.4. Market Attractiveness Analysis By Product Type 9. Cardiac Resynchronization Therapy Market Analysis 2017-2021 and Forecast 2022-2032, By End-User 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Mn) Analysis By End-User, 2017-2021 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End-User, 2022-2032 9.3.1. Commercial 9.3.2. Cardiac center 9.3.3. Other End-Users 9.4. Market Attractiveness Analysis By End-User 10. Cardiac Resynchronization Therapy Market Analysis 2017-2021 and Forecast 2022-2032, By Region 10.1. Introduction 10.2. Historical Market Size (US$ Mn) Analysis By Region, 2017-2021 10.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032 10.3.1. North America 10.3.2. Latin America 10.3.3. Europe 10.3.4. APAC 10.3.5. Middle East and Africa (MEA) 10.4. Market Attractiveness Analysis By Region 11. North America Cardiac Resynchronization Therapy Market Analysis 2017-2021 and Forecast 2022-2032 11.1. Introduction 11.2. Pricing Analysis 11.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 11.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 11.4.1. By Country 11.4.1.1. U.S. 11.4.1.2. Canada 11.4.2. By Product Type 11.4.3. By End-User 11.5. Market Attractiveness Analysis 11.5.1. By Country 11.5.2. By Product Type 11.5.3. By End-User 12. Latin America Cardiac Resynchronization Therapy Market Analysis 2017-2021 and Forecast 2022-2032 12.1. Introduction 12.2. Pricing Analysis 12.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 12.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 12.4.1. By Country 12.4.1.1. Brazil 12.4.1.2. Mexico 12.4.1.3. Rest of Latin America 12.4.2. By Product Type 12.4.3. By End-User 12.5. Market Attractiveness Analysis 12.5.1. By Country 12.5.2. By Product Type 12.5.3. By End-User 13. Europe Cardiac Resynchronization Therapy Market Analysis 2017-2021 and Forecast 2022-2032 13.1. Introduction 13.2. Pricing Analysis 13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 13.4.1. By Country 13.4.1.1. Germany 13.4.1.2. France 13.4.1.3. U.K. 13.4.1.4. Italy 13.4.1.5. Spain 13.4.1.6. Russia 13.4.1.7. Rest of Europe 13.4.2. By Product Type 13.4.3. By End-User 13.5. Market Attractiveness Analysis 13.5.1. By Country 13.5.2. By Product Type 13.5.3. By End-User 14. Asia Pacific Cardiac Resynchronization Therapy Market Analysis 2017-2021 and Forecast 2022-2032 14.1. Introduction 14.2. Pricing Analysis 14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 14.4.1. By Country 14.4.1.1. China 14.4.1.2. Japan 14.4.1.3. India 14.4.1.4. Australia 14.4.1.5. South Korea 14.4.1.6. Rest of Asia Pacific 14.4.2. By Product Type 14.4.3. By End-User 14.5. Market Attractiveness Analysis 14.5.1. By Country 14.5.2. By Product Type 14.5.3. By End-User 15. Middle East and Africa Cardiac Resynchronization Therapy Market Analysis 2017-2021 and Forecast 2022-2032 15.1. Introduction 15.2. Pricing Analysis 15.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 15.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 15.4.1. By Country 15.4.1.1. Saudi Arabia 15.4.1.2. South Africa 15.4.1.3. Israel 15.4.1.4. UAE 15.4.1.5. Rest of Middle East and Africa 15.4.2. By Product Type 15.4.3. By End-User 15.5. Market Attractiveness Analysis 15.5.1. By Country 15.5.2. By Product Type 15.5.3. By End-User 16. Key Countries Cardiac Resynchronization Therapy Market Analysis 2017-2021 and Forecast 2022-2032 16.1. Introduction 16.1.1. Market Value Proportion Analysis, By Key Countries 16.1.2. Global Vs. Country Growth Comparison 16.2. US Cardiac Resynchronization Therapy Market Analysis 16.2.1. Value Proportion Analysis by Market Taxonomy 16.2.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032 16.2.2.1. By Product Type 16.2.2.2. By End-User 16.3. Canada Cardiac Resynchronization Therapy Market Analysis 16.3.1. Value Proportion Analysis by Market Taxonomy 16.3.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032 16.3.2.1. By Product Type 16.3.2.2. By End-User 16.4. Mexico Cardiac Resynchronization Therapy Market Analysis 16.4.1. Value Proportion Analysis by Market Taxonomy 16.4.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032 16.4.2.1. By Product Type 16.4.2.2. By End-User 16.5. Brazil Cardiac Resynchronization Therapy Market Analysis 16.5.1. Value Proportion Analysis by Market Taxonomy 16.5.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032 16.5.2.1. By Product Type 16.5.2.2. By End-User 16.6. Germany Cardiac Resynchronization Therapy Market Analysis 16.6.1. Value Proportion Analysis by Market Taxonomy 16.6.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032 16.6.2.1. By Product Type 16.6.2.2. By End-User 16.7. France Cardiac Resynchronization Therapy Market Analysis 16.7.1. Value Proportion Analysis by Market Taxonomy 16.7.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032 16.7.2.1. By Product Type 16.7.2.2. By End-User 16.8. Italy Cardiac Resynchronization Therapy Market Analysis 16.8.1. Value Proportion Analysis by Market Taxonomy 16.8.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032 16.8.2.1. By Product Type 16.8.2.2. By End-User 16.9. Australia Cardiac Resynchronization Therapy Market Analysis 16.9.1. Value Proportion Analysis by Market Taxonomy 16.9.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032 16.9.2.1. By Product Type 16.9.2.2. By End-User 16.10. UK Cardiac Resynchronization Therapy Market Analysis 16.10.1. Value Proportion Analysis by Market Taxonomy 16.10.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032 16.10.2.1. By Product Type 16.10.2.2. By End-User 16.11. India Cardiac Resynchronization Therapy Market Analysis 16.11.1. Value Proportion Analysis by Market Taxonomy 16.11.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032 16.11.2.1. By Product Type 16.11.2.2. By End-User 16.12. China Cardiac Resynchronization Therapy Market Analysis 16.12.1. Value Proportion Analysis by Market Taxonomy 16.12.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032 16.12.2.1. By Product Type 16.12.2.2. By End-User 16.13. Japan Cardiac Resynchronization Therapy Market Analysis 16.13.1. Value Proportion Analysis by Market Taxonomy 16.13.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032 16.13.2.1. By Product Type 16.13.2.2. By End-User 16.14. South Korea Cardiac Resynchronization Therapy Market Analysis 16.14.1. Value Proportion Analysis by Market Taxonomy 16.14.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032 16.14.2.1. By Product Type 16.14.2.2. By End-User 16.15. Israel Cardiac Resynchronization Therapy Market Analysis 16.15.1. Value Proportion Analysis by Market Taxonomy 16.15.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032 16.15.2.1. By Product Type 16.15.2.2. By End-User 16.16. South Africa Cardiac Resynchronization Therapy Market Analysis 16.16.1. Value Proportion Analysis by Market Taxonomy 16.16.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032 16.16.2.1. By Product Type 16.16.2.2. By End-User 16.17. UAE Cardiac Resynchronization Therapy Market Analysis 16.17.1. Value Proportion Analysis by Market Taxonomy 16.17.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032 16.17.2.1. By Product Type 16.17.2.2. By End-User 16.18. Spain Cardiac Resynchronization Therapy Market Analysis 16.18.1. Value Proportion Analysis by Market Taxonomy 16.18.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032 16.18.2.1. By Product Type 16.18.2.2. By End-User 16.19. Russia Cardiac Resynchronization Therapy Market Analysis 16.19.1. Value Proportion Analysis by Market Taxonomy 16.19.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032 16.19.2.1. By Product Type 16.19.2.2. By End-User 17. Market Structure Analysis 17.1. Market Analysis by Tier of Companies 17.2. Market Concentration 17.3. Market Share Analysis of Top Players 17.4. Market Presence Analysis 17.4.1. By Regional footprint of Players 17.4.2. Product footprint by Players 18. Competition Analysis 18.1. Competition Dashboard 18.2. Competition Benchmarking 18.3. Competition Deep Dive 18.3.1. Medtronic 18.3.1.1. Overview 18.3.1.2. Product Portfolio 18.3.1.3. Sales Footprint 18.3.1.4. Strategy Overview 18.3.2. Boston Scientific 18.3.2.1. Overview 18.3.2.2. Product Portfolio 18.3.2.3. Sales Footprint 18.3.2.4. Strategy Overview 18.3.3. Abbott Laboratories 18.3.3.1. Overview 18.3.3.2. Product Portfolio 18.3.3.3. Sales Footprint 18.3.3.4. Strategy Overview 18.3.4. Biotronik 18.3.4.1. Overview 18.3.4.2. Product Portfolio 18.3.4.3. Sales Footprint 18.3.4.4. Strategy Overview 18.3.5. MicroPort Scientific Corporation 18.3.5.1. Overview 18.3.5.2. Product Portfolio 18.3.5.3. Sales Footprint 18.3.5.4. Strategy Overview 18.3.6. Medico 18.3.6.1. Overview 18.3.6.2. Product Portfolio 18.3.6.3. Sales Footprint 18.3.6.4. Strategy Overview 18.3.7. Scranton Gillette 18.3.7.1. Overview 18.3.7.2. Product Portfolio 18.3.7.3. Sales Footprint 18.3.7.4. Strategy Overview 19. Assumptions and Acronyms Used 20. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Cardiac Resynchronization Therapy Market Value (US$ Mn), By Product Type, 2015 – 2021
Table 2: Global Cardiac Resynchronization Therapy Market Value (US$ Mn), By Product Type, 2022 – 2032
Table 3: Global Cardiac Resynchronization Therapy Market Value (US$ Mn), By End-User, 2015 – 2021
Table 4: Global Cardiac Resynchronization Therapy Market Value (US$ Mn), By End-User, 2022 – 2032
Table 5: Global Cardiac Resynchronization Therapy Market, By Region, 2015 – 2021
Table 6: Global Cardiac Resynchronization Therapy Market, By Region, 2022 – 2032
Table 7: North America Cardiac Resynchronization Therapy Market Value (US$ Mn), By Product Type, 2015 – 2021
Table 8: North America Cardiac Resynchronization Therapy Market Value (US$ Mn), By Product Type, 2022 – 2032
Table 9: North America Cardiac Resynchronization Therapy Market Value (US$ Mn), By End-User, 2015 – 2021
Table 10: North America Cardiac Resynchronization Therapy Market Value (US$ Mn), By End-User, 2022 – 2032
Table 11: North America Cardiac Resynchronization Therapy Market, By Country, 2015 – 2021
Table 12: North America Cardiac Resynchronization Therapy Market, By Country, 2022 – 2032
Table 13: Latin America Cardiac Resynchronization Therapy Market Value (US$ Mn), By Product Type, 2015 – 2021
Table 14: Latin America Cardiac Resynchronization Therapy Market Value (US$ Mn), By Product Type, 2022 – 2032
Table 15: Latin America Cardiac Resynchronization Therapy Market Value (US$ Mn), By End-User, 2015 – 2021
Table 16: Latin America Cardiac Resynchronization Therapy Market Value (US$ Mn), By End-User, 2022 – 2032
Table 17: Latin America Cardiac Resynchronization Therapy Market, By Country, 2015 – 2021
Table 18: Latin America Cardiac Resynchronization Therapy Market, By Country, 2022 – 2032
Table 19: Europe Cardiac Resynchronization Therapy Market Value (US$ Mn), By Product Type, 2015 – 2021
Table 20: Europe Cardiac Resynchronization Therapy Market Value (US$ Mn), By Product Type, 2022 – 2032
Table 21: Europe Cardiac Resynchronization Therapy Market Value (US$ Mn), By End-User, 2015 – 2021
Table 22: Europe Cardiac Resynchronization Therapy Market Value (US$ Mn), By End-User, 2022 – 2032
Table 23: Europe Cardiac Resynchronization Therapy Market, By Country, 2015 – 2021
Table 24: Europe Cardiac Resynchronization Therapy Market, By Country, 2022 – 2032
Table 25: Asia Pacific Cardiac Resynchronization Therapy Market Value (US$ Mn), By Product Type, 2015 – 2021
Table 26: Asia Pacific Cardiac Resynchronization Therapy Market Value (US$ Mn), By Product Type, 2022 – 2032
Table 27: Asia Pacific Cardiac Resynchronization Therapy Market Value (US$ Mn), By End-User, 2015 – 2021
Table 28: Asia Pacific Cardiac Resynchronization Therapy Market Value (US$ Mn), By End-User, 2022 – 2032
Table 29: Asia Pacific Cardiac Resynchronization Therapy Market, By Country, 2015 – 2021
Table 30: Asia Pacific Cardiac Resynchronization Therapy Market, By Country, 2022 – 2032
Table 31: MEA Cardiac Resynchronization Therapy Market Value (US$ Mn), By Product Type, 2015 – 2021
Table 32: MEA Cardiac Resynchronization Therapy Market Value (US$ Mn), By Product Type, 2022 – 2032
Table 33: MEA Cardiac Resynchronization Therapy Market Value (US$ Mn), By End-User, 2015 – 2021
Table 34: MEA Cardiac Resynchronization Therapy Market Value (US$ Mn), By End-User, 2022 – 2032
Table 35: MEA Cardiac Resynchronization Therapy Market, By Country, 2015 – 2021
Table 36: MEA Cardiac Resynchronization Therapy Market, By Country, 2022 – 2032
Table 37: Global Cardiac Resynchronization Therapy Market Incremental $ Opportunity, By Product Type, 2015 - 2021
Table 38: Global Cardiac Resynchronization Therapy Market Incremental $ Opportunity, By End-User, 2022 – 2032
Table 39: Global Cardiac Resynchronization Therapy Market Incremental $ Opportunity, By Region, 2022 – 2032
Table 40: North America Cardiac Resynchronization Therapy Market Incremental $ Opportunity, By Product Type, 2015 - 2021
Table 41: North America Cardiac Resynchronization Therapy Market Incremental $ Opportunity, By End-User, 2022 – 2032
Table 42: North America Cardiac Resynchronization Therapy Market Incremental $ Opportunity, By Country, 2022 – 2032
Table 43: Latin America Cardiac Resynchronization Therapy Market Incremental $ Opportunity, By Product Type, 2015 - 2021
Table 44: Latin America Cardiac Resynchronization Therapy Market Incremental $ Opportunity, By End-User, 2022 – 2032
Table 45: Latin America Cardiac Resynchronization Therapy Market Incremental $ Opportunity, By Country, 2022 – 2032
Table 46: Europe Cardiac Resynchronization Therapy Market Incremental $ Opportunity, By Product Type, 2015 - 2021
Table 47: Europe Cardiac Resynchronization Therapy Market Incremental $ Opportunity, By End-User, 2022 – 2032
Table 48: Europe Cardiac Resynchronization Therapy Market Incremental $ Opportunity, By Country, 2022 - 2032
Table 49: Asia Pacific Cardiac Resynchronization Therapy Market Incremental $ Opportunity, By Product Type, 2015 - 2021
Table 50: Asia Pacific Cardiac Resynchronization Therapy Market Incremental $ Opportunity, By End-User, 2022 – 2032
Table 51: Asia Pacific Cardiac Resynchronization Therapy Market Incremental $ Opportunity, By Country, 2022 – 2032
Table 52: MEA Cardiac Resynchronization Therapy Market Incremental $ Opportunity, By Product Type, 2015 - 2021
Table 53: MEA Cardiac Resynchronization Therapy Market Incremental $ Opportunity, By End-User, 2022 – 2032
Table 54: MEA Cardiac Resynchronization Therapy Market Incremental $ Opportunity, By Country, 2022 - 2032
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Cardiac Resynchronization Therapy Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 2: Global Cardiac Resynchronization Therapy Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn
Figure 3: Global Cardiac Resynchronization Therapy Market Share, By Product Type, 2022 & 2032
Figure 4: Global Cardiac Resynchronization Therapy Market Y-o-Y Growth Projections, By Product Type – 2022-2032
Figure 5: Global Cardiac Resynchronization Therapy Market Attractiveness Index, By Product Type – 2022-2032
Figure 6: Global Cardiac Resynchronization Therapy Market Share, By End-User, 2022 & 2032
Figure 7: Global Cardiac Resynchronization Therapy Market Y-o-Y Growth Projections, By End-User – 2022-2032
Figure 8: Global Cardiac Resynchronization Therapy Market Attractiveness Index, By End-User – 2022-2032
Figure 9: Global Cardiac Resynchronization Therapy Market Share, By Region, 2022 & 2032
Figure 10: Global Cardiac Resynchronization Therapy Market Y-o-Y Growth Projections, By Region – 2022-2032
Figure 11: Global Cardiac Resynchronization Therapy Market Attractiveness Index, By Region – 2022-2032
Figure 12: North America Cardiac Resynchronization Therapy Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 13: North America Cardiac Resynchronization Therapy Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 14: North America Cardiac Resynchronization Therapy Market Share, By Product Type, 2022 & 2032
Figure 15: North America Cardiac Resynchronization Therapy Market Y-o-Y Growth Projections, By Product Type – 2022-2032
Figure 16: North America Cardiac Resynchronization Therapy Market Attractiveness Index, By Product Type – 2022-2032
Figure 17: North America Cardiac Resynchronization Therapy Market Share, By End-User, 2022 & 2032
Figure 18: North America Cardiac Resynchronization Therapy Market Y-o-Y Growth Projections, By End-User – 2022-2032
Figure 19: North America Cardiac Resynchronization Therapy Market Attractiveness Index, By End-User – 2022-2032
Figure 20: North America Cardiac Resynchronization Therapy Market Share, By Country, 2022 & 2032
Figure 21: North America Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 22: North America Market Attractiveness Index, By Country – 2022-2032
Figure 23: Latin America Cardiac Resynchronization Therapy Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 24: Latin America Cardiac Resynchronization Therapy Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 25: Latin America Cardiac Resynchronization Therapy Market Share, By Product Type, 2022 & 2032
Figure 26: Latin America Cardiac Resynchronization Therapy Market Y-o-Y Growth Projections, By Product Type – 2022-2032
Figure 27: Latin America Cardiac Resynchronization Therapy Market Attractiveness Index, By Product Type – 2022-2032
Figure 28: Latin America Cardiac Resynchronization Therapy Market Share, By End-User, 2022 & 2032
Figure 29: Latin America Cardiac Resynchronization Therapy Market Y-o-Y Growth Projections, By End-User – 2022-2032
Figure 30: Latin America Cardiac Resynchronization Therapy Market Attractiveness Index, By End-User – 2022-2032
Figure 31: Latin America Cardiac Resynchronization Therapy Market Share, By Country, 2022 & 2032
Figure 32: Latin America Cardiac Resynchronization Therapy Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 33: Latin America Cardiac Resynchronization Therapy Market Attractiveness Index, By Country – 2022-2032
Figure 34: Europe Cardiac Resynchronization Therapy Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 35: Europe Cardiac Resynchronization Therapy Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 36: Europe Cardiac Resynchronization Therapy Market Share, By Product Type, 2022 & 2032
Figure 37: Europe Cardiac Resynchronization Therapy Market Y-o-Y Growth Projections, By Product Type – 2022-2032
Figure 38: Europe Cardiac Resynchronization Therapy Market Attractiveness Index, By Product Type – 2022-2032
Figure 39: Europe Cardiac Resynchronization Therapy Market Share, By End-User, 2022 & 2032
Figure 40: Europe Cardiac Resynchronization Therapy Market Y-o-Y Growth Projections, By End-User – 2022-2032
Figure 41: Europe Cardiac Resynchronization Therapy Market Attractiveness Index, By End-User – 2022-2032
Figure 42: Europe Cardiac Resynchronization Therapy Market Share, By Country, 2022 & 2032
Figure 43: Europe Cardiac Resynchronization Therapy Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 44: Europe Cardiac Resynchronization Therapy Market Attractiveness Index, By Country – 2022-2032
Figure 45: MEA Cardiac Resynchronization Therapy Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 46: MEA Cardiac Resynchronization Therapy Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 47: MEA Cardiac Resynchronization Therapy Market Share, By Product Type, 2022 & 2032
Figure 48: MEA Cardiac Resynchronization Therapy Market Y-o-Y Growth Projections, By Product Type – 2022-2032
Figure 49: MEA Cardiac Resynchronization Therapy Market Attractiveness Index, By Product Type – 2022-2032
Figure 50: MEA Cardiac Resynchronization Therapy Market Share, By End-User, 2022 & 2032
Figure 51: MEA Cardiac Resynchronization Therapy Market Y-o-Y Growth Projections, By End-User – 2022-2032
Figure 52: MEA Cardiac Resynchronization Therapy Market Attractiveness Index, By End-User – 2022-2032
Figure 53: MEA Cardiac Resynchronization Therapy Market Share, By Country, 2022 & 2032
Figure 54: MEA Cardiac Resynchronization Therapy Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 55: MEA Cardiac Resynchronization Therapy Market Attractiveness Index, By Country – 2022-2032
Figure 56: Asia Pacific Cardiac Resynchronization Therapy Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 57: Asia Pacific Cardiac Resynchronization Therapy Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 58: Asia Pacific Cardiac Resynchronization Therapy Market Share, By Product Type, 2022 & 2032
Figure 59: Asia Pacific Cardiac Resynchronization Therapy Market Y-o-Y Growth Projections, By Product Type – 2022-2032
Figure 60: Asia Pacific Cardiac Resynchronization Therapy Market Attractiveness Index, By Product Type – 2022-2032
Figure 61: Asia Pacific Cardiac Resynchronization Therapy Market Share, By End-User, 2022 & 2032
Figure 62: Asia Pacific Cardiac Resynchronization Therapy Market Y-o-Y Growth Projections, By End-User – 2022-2032
Figure 63: Asia Pacific Cardiac Resynchronization Therapy Market Attractiveness Index, By End-User – 2022-2032
Figure 64: Asia Pacific Cardiac Resynchronization Therapy Market Share, By Country, 2022 & 2032
Figure 65: Asia Pacific Cardiac Resynchronization Therapy Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 66: Asia Pacific Cardiac Resynchronization Therapy Market Attractiveness Index, By Country – 2022-2032
Figure 67: US Cardiac Resynchronization Therapy Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 68: US Cardiac Resynchronization Therapy Market Share, By Product Type, 2021
Figure 69: US Cardiac Resynchronization Therapy Market Share, By End-User, 2021
Figure 70: Canada Cardiac Resynchronization Therapy Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 71: Canada Cardiac Resynchronization Therapy Market Share, By Product Type, 2021
Figure 72: Canada Cardiac Resynchronization Therapy Market Share, By End-User, 2021
Figure 73: Brazil Cardiac Resynchronization Therapy Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 74: Brazil Cardiac Resynchronization Therapy Market Share, By Product Type, 2021
Figure 75: Brazil Cardiac Resynchronization Therapy Market Share, By End-User, 2021
Figure 76: Mexico Cardiac Resynchronization Therapy Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 77: Mexico Cardiac Resynchronization Therapy Market Share, By Product Type, 2021
Figure 78: Mexico Cardiac Resynchronization Therapy Market Share, By End-User, 2021
Figure 79: Germany Cardiac Resynchronization Therapy Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 80: Germany Cardiac Resynchronization Therapy Market Share, By Product Type, 2021
Figure 81: Germany Cardiac Resynchronization Therapy Market Share, By End-User, 2021
Figure 82: U.K. Cardiac Resynchronization Therapy Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 83: U.K. Cardiac Resynchronization Therapy Market Share, By Product Type, 2021
Figure 84: U.K. Cardiac Resynchronization Therapy Market Share, By End-User, 2021
Figure 85: France Cardiac Resynchronization Therapy Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 86: France Cardiac Resynchronization Therapy Market Share, By Product Type, 2021
Figure 87: France Cardiac Resynchronization Therapy Market Share, By End-User, 2021
Figure 88: Italy Cardiac Resynchronization Therapy Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 89: Italy Cardiac Resynchronization Therapy Market Share, By Product Type, 2021
Figure 90: Italy Cardiac Resynchronization Therapy Market Share, By End-User, 2021
Figure 91: BENELUX Cardiac Resynchronization Therapy Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 92: BENELUX Cardiac Resynchronization Therapy Market Share, By Product Type, 2021
Figure 93: BENELUX Cardiac Resynchronization Therapy Market Share, By End-User, 2021
Figure 94: Nordic Countries Cardiac Resynchronization Therapy Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 95: Nordic Countries Cardiac Resynchronization Therapy Market Share, By Product Type, 2021
Figure 96: Nordic Countries Cardiac Resynchronization Therapy Market Share, By End-User, 2021
Figure 97: China Cardiac Resynchronization Therapy Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 98: China Cardiac Resynchronization Therapy Market Share, By Product Type, 2021
Figure 99: China Cardiac Resynchronization Therapy Market Share, By End-User, 2021
Figure 100: Japan Cardiac Resynchronization Therapy Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 101: Japan Cardiac Resynchronization Therapy Market Share, By Product Type, 2021
Figure 102: Japan Cardiac Resynchronization Therapy Market Share, By End-User, 2021
Figure 103: South Korea Cardiac Resynchronization Therapy Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 104: South Korea Cardiac Resynchronization Therapy Market Share, By Product Type, 2021
Figure 105: South Korea Cardiac Resynchronization Therapy Market Share, By End-User, 2021
Figure 106: GCC Countries Cardiac Resynchronization Therapy Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 107: GCC Countries Cardiac Resynchronization Therapy Market Share, By Product Type, 2021
Figure 108: GCC Countries Cardiac Resynchronization Therapy Market Share, By End-User, 2021
Figure 109: South Africa Cardiac Resynchronization Therapy Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 110: South Africa Cardiac Resynchronization Therapy Market Share, By Product Type, 2021
Figure 111: South Africa Cardiac Resynchronization Therapy Market Share, By End-User, 2021
Figure 112: Turkey Cardiac Resynchronization Therapy Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 113: Turkey Cardiac Resynchronization Therapy Market Share, By Product Type, 2021
Figure 114: Turkey Cardiac Resynchronization Therapy Market Share, By End-User, 2021
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How much is the current worth of the Cardiac Resynchronization Therapy market?
The global Cardiac Resynchronization Therapy market is worth US$ 6.1 Bn at present.
What is the sales forecast for Cardiac Resynchronization Therapy?
Value of Cardiac Resynchronization Therapy is projected to increase at a CAGR of around 7.9% during 2022 – 2032.
What was the last 5 year’s market CAGR?
Value of Cardiac Resynchronization Therapy increased at a CAGR of around 8% during 2017 – 2021.
Which segment has a better grip over the market in terms of product type in the year 2021?
CRT-Defibrillator has better stats, accounting for more than 58% of global revenue when compared with CRT-Pacemaker in 2021
What is a key trend shaping the growth of the market for Cardiac Resynchronization Therapy?
The growing importance of CRT-D devices and a variety of additional devices which have become more common in recent years (as the frequency and mortality of cardiovascular diseases have increased-CVD) are some of the major key trends shaping the growth of
Which are the top 5 countries driving demand for Cardiac Resynchronization Therapy?
The top 5 countries driving the demand for Cardiac Resynchronization Therapy are the U.S., China, Canada, India, and the UK
What is the outlook for the market in North America?
North America accounted for over 40% of global Cardiac Resynchronization Therapy demand in 2021.
At what percentage is sales of Cardiac Resynchronization Therapy going to register growth in Europe?
The European market for Cardiac Resynchronization Therapy is projected to expand at a CAGR of around 8.2% during 2022 – 2032.
What do statistics for South Korea and Japan reveal?
While the market in South Korea is expected to grow at nearly 6.9%, the market in Japan is projected to register a CAGR of nearly 9.6% during 2022 - 2032.
Cardiac Resynchronization Therapy Market